Source: Tech – South China Morning PostUS President Donald Trump’s latest round of tariffs targeting imported branded pharmaceutical products would “barely dent” the operations of major Chinese drug makers, according to analysts.
The new 100 per cent tariff on any branded or patented pharmaceutical product would apply to all imports, according to Trump’s post on his social media platform Truth Social on Thursday. Exemptions, however, would cover firms that have already broken ground on building a manufacturing plant in the US.
Drugs…Read More